Methotrexate therapy of psoriasis: Differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate

Journal of Investigative Dermatology

Volumn 104, Issue 2, 1995, Pages 183-188

  Jeffes III, E W B ^a   McCullough, J L ^a   Pittelkow, M R ^a   McCormick, A ^a   Almanzor, J ^a   Liu, G ^a   Dang, M ^a   Voss, K ^a   Voss, J ^a   Schlotzhauer, A ^a   Weinstein, G D ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Keratinocyte; Lymphocyte

Indexed keywords

METHOTREXATE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOCYTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS;

EID: 0028877604     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12612745     Document Type: Article

References (40)

1. Van Scott Auerbach R. Weinstein G. Parenteral methotrexate in psoriasis Arch Dermatol 89 1964 550 556
2. Nyfors A. Brodthagen H. Methotrexate for psoriasis in weekly oral doses without any adjunctive therapy Dermatologica 140 1970 345 355
3. Weinstein G. Goldfaden G. Frost P. Methotrexate: mechanism of action on DNA synthesis in psoriasis Arch Dermatol 104 1971 236 243
4. Weinstein G. Velasco J. Selective action of methotrexate on psoriatic epidermal cells J Invest Dermatol 59 1972 121 127
5. Newburger A. Weinstein G. McCullough J. Biological and biochemical reactions of methotrexate in psoriasis J Invest Dermatol 70 1978 183 186
6. Ellis C. Gorsulowsky D. Hamilton T. Billings J. Brown M. Headington J. Cooper K. Baadsgaard O. Duell E. Annesley T. Turcotte J. Voorhees J. Cyclosporin improves psoriasis in a double-blind study JAMA 256 1986 3110 3116
7. Baker B. Griffiths C. Sambert S. The effects of cyclosporin A on T lymphocyte and dendritic cell subpopulations in psoriasis Br J Dermatol 116 1987 503 510
8. Gottlieb A. Grossman R. Khandke L. Carter M. Sehgal P. Fu S. Granelli-Piperno A. Rivas M. Barazani L. Krueger J. Studies of the effect of cyclosporine in psoriasis in vivo: Combined effects on activated T lymphocytes and epidermal regenerative maturation J Invest Dermatol 98 1992 302 309
9. + perivascular dendritic cells J Invest Dermatol 96 1991 333 340
10. Weinstein G. Jeffes E. McCullough J. Cytotoxic and immunologic effects of methotrexate in psoriasis J Invest Dermatol 95 1990 495 525
11. Halprin K. Fukui K. Ohkawara A. Blood levels of methotrexate and the treatment of psoriasis Arch Dermatol 103 1971 243 249
12. Kamel R. Al-Hakiem H. Rademaker M. Thomas R. Pharmacokinetics of small doses of methotrexate in patients with psoriasis Acta Derm Venerol (Stockh) 68 1988 267 270
13. Sinnet M. Groff G. Raddatz D. Franck W. Bertino J. Methotrexate pharmacokinetics in patients with rheumatoid arthritis J Rheumatol 16 1989 745 748
14. Wille J.J. Jr Pittelkow M.R. Shipley G.D. Scott R.E. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies J Cell Physiol 121 1984 31 44
15. Ciancio G. Pollack A. Taupier M.A. Block N.L. Irvin G.L. III Measurement of cell-cycle phase-specific cell death using Hoerchst 33342 and propidium iodide: preservation by ethanol fixation J Histochem Cytochem 36 1988 1147 1152
16. Eichholtz H. Trott K. Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro Br J Cancer 41 1980 277 284
17. Keefe D. Capizzi R. Rudnick S. Methotrexate cytotoxicity for L5178Y/Asn lymphoblasts: relationship of dose and duration of exposure to tumor cell viability Cancer Res 42 1982 1641 1645
18. De Abreu R. Bokkerink J. Bakker A. Hulscher T. De Vaan G. De Bruijn C. Schretlen D. Synergy of methotrexate and 6-mercaptopurine on cell growth and clonogenicity of cultured human T-lymphoblasts Adv Exp Med 195 1986 129 134
19. Holden L. Hoffbrand A.V. Tattersall H.N. Thymidine concentrations in human sera: variations with leukemia and megaloblastic anemia Eur J Cancer 16 1980 115 121
20. Schaer J.-C. Maurer U. Schindler R. Determination of thymidine in serum used for cell culture media Exp Cell Biol 46 1978 1 10
21. McCullough J. Snyder D. Weinstein G. Friedland A. Stein B. Factors affecting human percutaneous penetration of methotrexate and its analogues in vitro J Invest Dermatol 66 1976 103 107
22. Weinstein G. McCullough J. Cytokinetics and chemotherapy of psoriasis J Invest Dermatol 67 1976 26 30
23. McCullough J. Weinstein G. Hynes J. Pharmacologic aspects of screening new folic acid antagonists for topical use in psoriasis E. Fargber A. Cox Proceedings of the International Symposium for Psoriasis 1977 Stanford University Press 424 426
24. McCullough J. Weinstein G. The role of cell kinetics in the chemotherapy of hyperproliferative skin diseases: a review J Pharmacol Ther 7 1979 601 615
25. Weinstein G. McCullough J. Eaglstein W. Golub A. A clinical screening program for topical chemotherapeutic drugs in psoriasis Arch Dermatol 117 1981 388 393
26. Lowe N. Stoughton R. McCullough J. Weinstein G. Topical drug effects on normal and proliferating epidermal cell models: a comparison with responses in psoriatics Arch Dermatol 117 1981 394 398
27. Ball M. McCullough J. Weinstein G. Percutaneous absorption of methotrexate: effect on epidermal DNA synthesis in hairless mice J Invest Dermatol 79 1982 7 10
28. Bjerring P. Beck H. Zachariae H. Sogaard H. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study Acta Derm Venereol (Stockh) 66 1986 515 519
29. Roenick H. Fowler-Bergfeld W. Curtis G. Methotrexate for psoriasis in weekly oral doses Arch Dermatol 99 1969 86 93
30. Weinstein G. Frost P. Methotrexate for psoriasis. A new therapeutic schedule Arch Dermatol 103 1971 33 38
31. Zachariae H. Zachariae E. Methotrexate treatment of psoriatic arthritis Acta Derm Venereol 67 1987 270 273
32. Andersen P. West S. O'Dell J. Weekly pulse methotrexate in rheumatoid arthritis Ann Intern Med 103 1985 489 496
33. Kaplan M. Knox T. Treatment of primary biliary cirrhosis with low dose weekly methotrexate Gastroenterology 101 1991 1332 1338
34. Johnson W. DiMartino M. Meunier P. Muirhead K. Hanna N. Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis J Rheumatol 15 1988 745 749
35. Wigginton S. Chu B. Weisman M. Howell S. Methotrexate pharmacokinetics after intraarticular injection in patients with rheumatoid arthritis Arthritis Rheum 23 1980 119 122
36. Marks J. Stewart I. Hunter J. Intra-articular methotrexate in rheumatoid arthritis Lancet 2 1976 857 858
37. Russell A. Activated lymphocytes in peripheral blood of patients with rheumatoid arthritis J Rheumatol 17 1990 589 590
38. Carter S. Bacon P. Hall N. Characterization of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis Ann Rheum Dis 40 1981 293 298
39. Al-Balaghi S. Strom H. Moller E. Spontaneous DNA synthesis in rheumatoid arthritis: evidence of enhanced circulating Non-T cell proliferation Scand J Immnnol 17 1983 521 530
40. Nykanen P. Bergroth V. Raunino P. Nordstrom D. Donttinen Y. Phenotypic characterization of 3H-thymidine incorporating cells in rheumatoid arthritis synovial membrane Rheumatol Int 6 1986 269 271